IDEAYA Biosciences, Inc.IDYA

NasdaqHealthcarePharmaceutical Preparations
Price (close)
$36.74
Market cap
$3.5B
P/E
—
Revenue (TTM)
$234.1M
Net income
-$175.0M
Dividend yield
—
1-year total return
43.0%
Net margin
-74.8%
Revenue growth
—
Debt / equity
—

What IDEAYA Biosciences, Inc. does.

No business description on file yet.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue$19.5M$27.9M$50.9M$23.4M$7.0M$218.7M
Net income-$34.5M-$49.8M-$58.7M-$113.0M-$274.5M-$113.7M
Free cash flow$55.0M-$58.4M-$90.6M-$117.6M-$251.4M-$73.5M

More on IDYA.

Figures from IDEAYA Biosciences, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.